Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma

Invasive mucinous adenocarcinoma (IMA) is a special type of lung adenocarcinoma that accounts for 2% to 10% of all lung adenocarcinoma. Surgical treatment is preferred for IMA, and traditional chemotherapy drugs and targeted therapy drugs have poor efficacy in this disease. IMA has unique prognostic...

Full description

Saved in:
Bibliographic Details
Main Authors: Minjun SHI, Bo YE
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180919125606400
author Minjun SHI
Bo YE
author_facet Minjun SHI
Bo YE
author_sort Minjun SHI
collection DOAJ
description Invasive mucinous adenocarcinoma (IMA) is a special type of lung adenocarcinoma that accounts for 2% to 10% of all lung adenocarcinoma. Surgical treatment is preferred for IMA, and traditional chemotherapy drugs and targeted therapy drugs have poor efficacy in this disease. IMA has unique prognostic, imaging and molecular features. The incidence of IMA is very low, so thoracic surgeons may lack of knowledge to the disease and misdiagnose it as benign diseases such as pneumonia and tuberculosis. This article reviews and discusses the imaging, clinicopathological features, treatment methods and prognosis of IMA.
format Article
id doaj-art-cd77611da26547dab932aa994845c057
institution OA Journals
issn 1009-3419
1999-6187
language zho
publishDate 2024-09-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj-art-cd77611da26547dab932aa994845c0572025-08-20T02:18:00ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872024-09-0127968569010.3779/j.issn.1009-3419.2024.106.22Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous AdenocarcinomaMinjun SHI0Bo YE1Department of Thoratic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, 
Shanghai 200030, ChinaDepartment of Thoratic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, 
Shanghai 200030, ChinaInvasive mucinous adenocarcinoma (IMA) is a special type of lung adenocarcinoma that accounts for 2% to 10% of all lung adenocarcinoma. Surgical treatment is preferred for IMA, and traditional chemotherapy drugs and targeted therapy drugs have poor efficacy in this disease. IMA has unique prognostic, imaging and molecular features. The incidence of IMA is very low, so thoracic surgeons may lack of knowledge to the disease and misdiagnose it as benign diseases such as pneumonia and tuberculosis. This article reviews and discusses the imaging, clinicopathological features, treatment methods and prognosis of IMA.http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.22lung neoplasmsinvasive mucinous adenocarcinomamolecule mechanismtreatment
spellingShingle Minjun SHI
Bo YE
Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
Chinese Journal of Lung Cancer
lung neoplasms
invasive mucinous adenocarcinoma
molecule mechanism
treatment
title Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
title_full Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
title_fullStr Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
title_full_unstemmed Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
title_short Advances on Molecular Mechanism and Clinical Treatment 
in Invasive Mucinous Adenocarcinoma
title_sort advances on molecular mechanism and clinical treatment 
in invasive mucinous adenocarcinoma
topic lung neoplasms
invasive mucinous adenocarcinoma
molecule mechanism
treatment
url http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.22
work_keys_str_mv AT minjunshi advancesonmolecularmechanismandclinicaltreatmentininvasivemucinousadenocarcinoma
AT boye advancesonmolecularmechanismandclinicaltreatmentininvasivemucinousadenocarcinoma